Bristol Stock News Today

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;padding-top: 25px;;'>BM</div>
BMY -- USA Stock  

Report: 6th of August 2020  

Bristol Stock News module provides quick insight into current market opportunities from investing in Bristol Myers Squibb. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Bristol Myers Squibb stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Continue to Bristol Myers Hype Analysis, Bristol Myers Correlation and Bristol Myers Performance.

Search Today's Stock News

 
Refresh
Bristol Myers stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bristol daily returns and investor perception about the current pice of Bristol Myers Squibb as well as its diversification or hedging effects on your existing portfolios.
  
3 days ago at simplywall.st         
Heres Why Bristol-Myers Squibbs Statutory Earnings Are Arguably Too Conservative - Simply Wall St
Simply Wall St News at Macroaxis
Heres Why Bristol-Myers Squibbs Statutory Earnings Are Arguably Too Conservative Simply Wall St
  
  
few days ago at www.nasdaq.com         
Zacks.com featured highlights include Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek ...
nasdaq News
Zacks.com featured highlights include Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners Nasdaq
  
  
over a week ago at www.macroaxis.com         
Payment of 4463 shares by Samit Hirawat of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co officer. Payment of exercise price or tax liability by delivering or withholding securities
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Samit Hirawat of 9356 shares of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at simplywall.st         
It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company For Its Next Dividend - Simply Wall...
Simply Wall St News at Macroaxis
It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company For Its Next Dividend Simply Wall St
  
  
over two weeks ago at seekingalpha.com         
3 Reasons Bristol-Myers Squibb Could Make You Rich - Seeking Alpha
seekingalpha News
3 Reasons Bristol-Myers Squibb Could Make You Rich Seeking Alpha
  
  
over two weeks ago at www.macroaxis.com         
Bristol Myers exotic insider transaction detected
Macroaxis News
Filed transaction by Bristol Myers Squibb Co officer. Unconventional Insider trading
  
  
over three weeks ago at www.macroaxis.com         
Bristol Myers exotic insider transaction detected
Macroaxis News
Filed transaction by Bristol Myers Squibb Co director. Unconventional Insider trading
  
  
over three weeks ago at www.macroaxis.com         
Payment of 216 shares by Joseph Eid of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co officer. Payment of exercise price or tax liability by delivering or withholding securities
  
  
over three weeks ago at www.macroaxis.com         
Exercise or conversion by Julia Haller of 558 shares of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over three weeks ago at www.macroaxis.com         
Bristol Myers exotic insider transaction detected
Macroaxis News
Filed transaction by Bristol Myers Squibb Co director. Unconventional Insider trading
  
  
over a month ago at www.manchestertimes.com         
Exercise or conversion by Michael Bonney of 558 shares of Bristol Myers subject to Rule 16b-3
M
Filed transaction by Bristol Myers Squibb Co director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a month ago at www.macroaxis.com         
Payment of 863 shares by Daniels Brian of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co officer. Payment of exercise price or tax liability by delivering or withholding securities
  
  
over a month ago at www.macroaxis.com         
Exercise or conversion by Joseph Eid of 2154 shares of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a month ago at www.macroaxis.com         
Exercise or conversion by Julia Haller of 2949 shares of Bristol Myers subject to Rule 16b-3
Macroaxis News
Filed transaction by Bristol Myers Squibb Co director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  

Investors are also looking into

Bristol Myers Performance against DOW

 Price Growth (%)  
      Timeline 
1
Exercise or conversion by Sigal Elliot of 11092 shares of Br...04/17/2020
2
Exercise or conversion by Cazala Beatrice J of 9386 shares o...04/20/2020
3
Acquisition by Coffman Vance D of 2000 shares of Bristol Mye...04/21/2020
4
Exercise or conversion by Sigal Elliot of 6875 shares of Bri...04/22/2020
5
Payment of 7634 shares by Lamberto Andreotti of Bristol Myer...04/23/2020
6
Acquisition by Matthew Emmens of 2946 shares of Bristol Myer...04/28/2020
7
Exercise or conversion by Christopher Boerner of 10953 share...04/30/2020
8
Bristol Myers exotic insider transaction detected05/01/2020
9
Purchase by Cornelius James M of 1858 shares of Bristol Myer...05/04/2020
10
Exercise or conversion by Nadim Ahmed of 2908 shares of Bris...05/05/2020
11
Bristol Myers exotic insider transaction detected05/06/2020
12
Acquisition by Thomas Lynch of 253 shares of Bristol Myers s...05/07/2020
13
Payment of 788 shares by Celentano John E of Bristol Myers s...05/11/2020
14
Acquisition by Cazala Beatrice J of 29293 shares of Bristol ...05/12/2020
15
Payment of 3187 shares by Sigal Elliot of Bristol Myers subj...05/13/2020
16
Sale by Lewis Campbell of 100 shares of Bristol Myers05/15/2020
17
Financial Statements05/19/2020
18
Buy Bristol-Myers Squibb For 25 percent Gains - Forbes05/20/2020
19
Acquisition or disposition of Bristol Myers securities by An...05/21/2020
20
Sale by Adam Dubow of 3200 shares of Bristol Myers05/22/2020
21
Bristol Myers exotic insider transaction detected05/26/2020
22
Exercise or conversion by Sandra Leung of 7355 shares of Bri...05/27/2020
23
Bristol Myers exotic insider transaction detected05/28/2020
24
Sale by Cornelius James M of 10000 shares of Bristol Myers05/29/2020
25
Exercise or conversion by Julia Haller of 2949 shares of Bri...06/03/2020
26
Bristol Myers exotic insider transaction detected06/04/2020
27
Exercise or conversion by Julia Haller of 2949 shares of Bri...06/05/2020
28
Exercise or conversion by Joseph Eid of 2154 shares of Brist...06/09/2020
29
Payment of 863 shares by Daniels Brian of Bristol Myers subj...06/10/2020
30
Bristol Myers exotic insider transaction detected06/15/2020
31
Exercise or conversion by Julia Haller of 558 shares of Bris...06/16/2020
32
Bristol Myers exotic insider transaction detected06/17/2020
33
Payment of 216 shares by Joseph Eid of Bristol Myers subject...06/18/2020
34
Bristol Myers exotic insider transaction detected06/22/2020
35
Payment of 4463 shares by Samit Hirawat of Bristol Myers sub...07/01/2020
36
Exercise or conversion by Samit Hirawat of 9356 shares of Br...07/02/2020
37
Heres Why Bristol-Myers Squibbs Statutory Earnings Are Argua...07/10/2020
Continue to Bristol Myers Hype Analysis, Bristol Myers Correlation and Bristol Myers Performance. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page